Bottom line
SHM vs XLV: the short answer
SHM (State Street(R) SPDR Nuveen ICE Short Term Municipal Bond ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
But SHM is far broader, holding 1,047 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
XLV is cheaper at 0.08% vs 0.2% — a difference of $12 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +0.7% for SHM.
Updated Nov 19, 2026
SHM vs XLV side by side
| SHM | XLV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | SPDR (State Street) |
| Category | Municipal Bond | Health Care Sector |
| Expense ratio | 0.2% | 0.08% |
| Annual cost per $10k | $20 | $8 |
| 10-yr cost on $10k (prospectus) | $255 | $103 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0.02% |
| 1-yr return | +3.8% | +14.5% |
| 5-yr return (annualized) | +0.7% | +8.1% |
| 10-yr return (annualized) | +1.2% | +9.8% |
| Best quarter | +3.8% | +14.5% |
| Worst quarter | −3.7% | −12.7% |
| Net assets (fund) | $3.5B | $40.6B |
| Number of holdings | 1,047 | 65 |
| Portfolio turnover | 34% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHM | XLV | Difference |
|---|---|---|---|
| 2025 | +3.8% | +14.5% | −10.8% |
| 2024 | +1.2% | +2.5% | −1.3% |
| 2023 | +3.0% | +2.0% | +1.0% |
| 2022 | −3.8% | −2.1% | −1.7% |
| 2021 | −0.3% | +25.9% | −26.2% |
| 2020 | +2.7% | +13.3% | −10.6% |
| 2019 | +3.5% | +20.7% | −17.1% |
| 2018 | +1.4% | +6.3% | −4.9% |
| 2017 | +1.3% | +21.7% | −20.4% |
| 2016 | −0.4% | −2.8% | +2.4% |
Source: Fund prospectus bar charts
Holdings overlap
SHM and XLV share none of their top holdings.
SHM top 10
- Southeast Energy Authority A Cooperative District — 0.92%
- State of California — 0.69%
- New York State Dormitory Authority — 0.61%
- State of California — 0.52%
- State of California — 0.49%
- State of California — 0.46%
- City of New York NY — 0.44%
- University of California — 0.41%
- Triborough Bridge & Tunnel Authority — 0.40%
- City of New York NY — 0.39%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between SHM and XLV?
Which is cheaper, SHM or XLV?
Should I own both SHM and XLV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.